Beijing, Beijing, China | Fund Name | Location |
| ATOORO FUND | Israel, Tel Aviv, Tel Aviv |
| ChainFunder | China, Shanghai |
| CIIE | Centre for Innovation Incubation and Entrepreneurship | - |
| Covestro | Germany, Leverkusen, Nordrhein-Westfalen |
| Crede CapitalGroup | California, Los Angeles, United States |
| Delta-v Capital | Boulder, Colorado, United States |
| Dumont Venture | Cologne, Germany, Nordrhein-Westfalen |
| Human Capital | California, San Francisco, United States |
| I-O Data Device | Ishikawa Prefecture, Japan, Kanazawa |
| IBI Investment House | - |
| Jan Cieslikiewicz Ventures | Brooklyn, New York, United States |
| Lanxum | Beijing, Beijing, China |
| Lianxun Zhengquan | China, Guangdong Province, Huangpu District |
| Lowercarbon Capital | - |
| LUN Partners Group | China, Hong Kong, Hong Kong Island |
| OKB Capital | Gifu, Gifu Prefecture, Japan |
| Prologis | California, San Francisco, United States |
| SCF Arizona | Arizona, Phoenix, United States |
| Valore Assoluto | - |
| Veron International | China, Hong Kong, Hong Kong Island |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Sciwind Biosciences | $30M | 13 Feb 2019 | Shangcheng District, Zhejiang, China |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Sciwind Biosciences | $30M | 13 Feb 2019 | Shangcheng District, Zhejiang, China |
Get matched with relevant funds
